Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06881550 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer Surgery

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 18, 2025 (before its estimated December 10, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Caigang Liu
4 trials monitored
See all monitored trials
Breast Cancer
5,418 trials monitored
See 296 trials at risk
This study aims to explore the clinical efficacy of Shenbailing granules in improving quality of life and reducing cancer-related fatigue in a real-world setting, with the goal of providing clinical evidence for the use of Shenbailing granules in alleviating cancer-related fatigue among post-breast cancer surgery patients.
Trial Details
NCT Number NCT06881550
Lead Sponsor Caigang Liu
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov